OR16 GPCRs, Growth Factors and Inhibins - Mechanisms, Genetics and Drug Discovery

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Growth Factor/Tyrosine Kinase/G Protein-Coupled Receptor/Intracelluar Signaling & Biology-Basic
Saturday, April 2, 2016: 11:45 AM-1:15 PM
Room 253 (BCEC)
Chairs:
To Be Determined and To Be Determined

Disclosure Not Provided: DRC, SJF, AVL
11:45 AM
Erik G. Strungs1, Mi Hye Lee, PhD1, Kathryn M. Appleton, PhD2 and Louis M. Luttrell, MD, PhD1, (1)Department of Medicine, Medical University of South Carolina, Charleston, SC
(2)Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, Charleston, SC
12:00 PM
Rikke Beck Jensen, Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark, Thomas Scheike, Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark, G.N. Ajay Thankamony, MRCPCH, MPhil, Pediatrics, University of Cambridge, Cambridge, UK, Cambridge, United Kingdom, David B Dunger, MD, FRCP, Paediatrics, University of Cambridge, Cambridge, United Kingdom, Steven W.J. Lamberts, MD PhD, Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands, Allan Vaag, Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark and Pernille Poulsen, Novo Nordisk, Denmark
12:15 PM
Qing He, Ph.D.1, Richard Bouley2, Zun Liu1, Marc Nathan Wein, MD/PhD1, Yan Zhu1, Jordan M Spatz1, Paola Divieti Pajevic3, Antonius Plagge4 and Murat Bastepe1, (1)Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
(2)Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA
(3)Boston University School of Dental Medicine
(4)Department of Cellular and Molecular Physiology, Institute of Translational Medicine University of Liverpool, Liverpool
12:30 PM
Sarah A Howles, DPhil1, Valerie N Babinsky, MSc2, Sian E Piret, DPhil1, Fadil M Hannan, PhD1, Angela Rogers2, Nigel Rust3, Michelle Stewart4, Tertius A Hough, PhD4, M Andrew Nesbit1, Sara Wells, PhD4, Roger D Cox, PhD4 and Rajesh V Thakker, FRS, FMedSci, FRCPath, FRCPE, FRCP2, (1)Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
(2)Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
(3)The Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
(4)MRC Harwell Mammalian Genetics Unit, United Kingdom
12:45 PM
Kelly Louise Walton, PhD1, Emily K Kelly1, Katharine Elizabeth Johnson1, David Mark Robertson, PhD2 and Craig Anthony Harrison, PhD1, (1)Growth Factor Signalling Laboratory, Hudson Institute of Medical Research, Clayton, VIC, Australia
(2)Reproductive Hormones Laboratory, Hudson Institute of Medical Research, Clayton, VIC, Australia
1:00 PM
Alexander I Agoulnik, PhD1, Xin Hu, PhD2, Irina U Agoulnik, PhD3, Zaohua Huang, PhD1, Courtney Myhr, MS1, Brian A Ho1, Elena Barnaeva2, Jingbo Xiao, PhD2, Marc Ferrer, PHD2, Noel T. Southall2 and Juan J. Marugan, PHD2, (1)Department of Human and Molecular Genetics, Herbert Wertheim College of Medicine, Florida International University, Miami, FL
(2)NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD
(3)Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire